Market Overview:

The Eye Infections Treatment Market size is estimated to reach $9.76 billion by 2030, growing at a CAGR of 3.7% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Eye Infections Treatment Market – By Category (Conjunctivitis, Blepharitis, Keratitis, Vitritis, Chorioretinitis, and Neuroretinitis), By Cause of Infection (Bacteria, Viruses, Irritants, and Allergies), By Drug Type (Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotic / Polypeptide Antibiotic / Corticosteroid Combinations, Aminoglycoside Antibiotics, Sulfa Antibiotics, and Others), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), By Geography –  Opportunity Analysis & Industry Forecast, 2024-2030”
The rising prevalence of eye infections and prevalence of contact lens-related infections are fueling the growth of the Eye Infections Treatment industry during the forecast period.

North America Dominated the Market in 2023:

North America dominated the eye infection treatment market in 2023, capturing over 39% of the total market share. This substantial portion reflects the region's high prevalence of eye infections, which affect millions annually. Common types such as conjunctivitis, keratitis, and endophthalmitis contribute significantly to the market's size. Factors driving this dominance include the widespread use of contact lenses, a rising number of individuals with diabetes and other chronic conditions, and an aging population increasingly susceptible to infections. The NIH reports that allergic conjunctivitis affects up to 40% of individuals, frequently requiring the attention of eye specialists. 

Eye Infections Treatment Market: Key Takeaways

Rising Prevalence of Eye Infections Drives the Demand for Eye Infections Treatment:

The rising prevalence of eye infections fuels demand for treatment due to new drugs, demographics, and surgical procedures. The WHO reported in June 2022 that 125 million people in trachoma-endemic regions risk blindness. This increasing incidence highlights the need for accessible solutions, boosting the demand for eye infection treatment globally. The growing global eye care market, propelled by an aging population and rising eye diseases, further supports this demand. Addressing the root causes of infections and innovating treatment options are essential to manage the increasing prevalence and safeguard eye health worldwide.

For More Queries About "Eye Infections Treatment Market " @ https://www.industryarc.com/Report/15846/eye-infections-treatment-market.html

Prevalence of Contact Lens-Related Infections is Driving the Market Growth:

The increasing prevalence of contact lens-related infections drives the demand for effective treatments. As contact lens use grows, so do associated eye infections, necessitating swift solutions. Factors such as increased lens usage and the desire for reliable remedies boost the demand for eye infection treatments. This surge highlights the critical need for advanced therapeutic interventions, promoting eye health and providing relief. Educating contact lens users on proper hygiene and care is also vital in preventing infections. Innovations in lens materials and solutions could further mitigate infection risks, supporting overall eye health. 

Scope of the Report: 

Report Metric

Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

3.7%

Market Size in 2030

$9.76 billion

Segments Covered

By Category, By Cause of Infection, By Drug Type, By Distribution Channels, and By Region



 

Geographies Covered

North America (U.S, Canada, and Mexico), Europe (U.K., Germany, France, Italy, Netherlands, Spain, Russia, Belgium, and Rest of Europe), APAC (China, Japan, India, South Korea, Australia, Taiwan, Indonesia, Malaysia, and Rest of Asia Pacific), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and RoW (Middle East and Africa).

 

 

 

 

Key Market Players

1.  Bausch Health Companies Inc.

2.  Novartis International AG

3.  Santen Pharmaceutical Co., Ltd.

4.  Pfizer

5.  Sun Eye Care Pharmaceuticals Pvt. Ltd.

6.  Ocular Therapeutix

7.  Johnson & Johnson Consumer Inc.

8.  GlaxoSmithKline Pharmaceuticals Ltd

9.  Alcon Inc.

10.  AbbVie Inc.

 

Recent Developments:

•    In March 2022, Bausch + Lomb and Clearside Biomedical launched XIPERE® in the U.S. for uveitis-related macular edema. Administered suprachoroidally, it's the only FDA-approved treatment for this specific eye inflammation. This offers a targeted therapeutic option for patients suffering from this vision-threatening condition.

•    In April 2022, Sandoz introduced generic brimonidine tartrate/timolol maleate eyedrops in the US. This expands its ophthalmic portfolio for ocular hypertension, reinforcing their dedication to affordable healthcare. The launch provides a more accessible treatment option for patients managing elevated eye pressure.

Eye Infections Treatment Market: Competitive Landscape

Key companies profiled in the Eye Infections Treatment Market are Bausch Health Companies Inc., Novartis International AG, Santen Pharmaceutical Co., Ltd., Pfizer, Sun Eye Care Pharmaceuticals Pvt. Ltd., Ocular Therapeutix, Johnson & Johnson Consumer Inc., GlaxoSmithKline Pharmaceuticals Ltd, Alcon Inc., AbbVie Inc., and others.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.
 
Contact Us:

Mr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727
Web: https://www.industryarc.com
Follow us on LinkedIn | Facebook | Twitter